SHAREHOLDER ALERT: Abeona Therapeutics Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm
01 mai 2024 16h30 HE
|
Block & Leviton LLP
BOSTON, May 01, 2024 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Abeona Therapeutics, Inc. (NASDAQ: ABEO) for potential securities law violations. Investors who have lost money in their...
SHAREHOLDER ALERT: Abeona Therapeutics Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm
23 avr. 2024 10h29 HE
|
Block & Leviton LLP
BOSTON, April 23, 2024 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Abeona Therapeutics, Inc. (NASDAQ: ABEO) for potential securities law violations. Investors who have lost money in...
CHARLES RIVER ALERT: Bragar Eagel & Squire, P.C. is Investigating Charles River Laboratories International, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
02 avr. 2024 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, April 02, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Charles River...
Investigation Alert CRL, FIS, GL, NSC: Johnson Fistel, LLP Encourages Long-Term Investors to Submit Their Information Below
08 août 2023 12h07 HE
|
Johnson Fistel, LLP
SAN DIEGO, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Charles River Laboratories International, Inc. Johnson Fistel, LLP is investigating potential claims on behalf of Charles River Laboratories...
Regeneron Pharmaceuticals Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm
25 juil. 2023 15h04 HE
|
Block & Leviton LLP
BOSTON, July 25, 2023 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) for potential securities law violations. Investors who have lost money...
Investigation Alert CRL, FIS, GL, NSC: Johnson Fistel, LLP Encourages Long-Term Investors to Submit Their Information Below
24 juil. 2023 10h17 HE
|
Johnson Fistel, LLP
SAN DIEGO, July 24, 2023 (GLOBE NEWSWIRE) -- Charles River Laboratories International, Inc. Johnson Fistel, LLP is investigating potential claims on behalf of Charles River Laboratories...
DEADLINE ALERT for CRL and VIRT: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
18 juil. 2023 12h16 HE
|
The Law Offices of Frank R. Cruz
LOS ANGELES, July 18, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
CRL FINAL DEADLINE TOMORROW: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Charles River Laboratories International, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important July 18 Deadline in Securities Class Action – CRL
17 juil. 2023 10h21 HE
|
The Rosen Law Firm PA
NEW YORK, July 17, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Charles River Laboratories International, Inc. (NYSE:...
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (NYSE: CRL) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Charles River Laboratories International, Inc.
11 juil. 2023 01h45 HE
|
Bernstein Liebhard LLP
NEW YORK, July 11, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own shares of Charles River Laboratories, Inc. (NYSE: CRL)?Did you purchase your shares between May 5, 2020...
DEADLINE ALERT for VTRS, CRL, and VIRT: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
10 juil. 2023 12h07 HE
|
The Law Offices of Frank R. Cruz
LOS ANGELES, July 10, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...